BKI Investment Company Limited (ASX:BKI)
Australia flag Australia · Delayed Price · Currency is AUD
1.890
+0.065 (3.56%)
Jul 31, 2025, 4:10 PM AEST

CTI BioPharma Revenue

In the fiscal year ending June 30, 2025, BKI Investment Company had annual revenue of 69.33M AUD with 1.45% growth. BKI Investment Company had revenue of 34.29M in the half year ending June 30, 2025, a decrease of -5.95%.

Revenue
69.33M
Revenue Growth
+1.45%
P/S Ratio
22.00
Revenue / Employee
34.67M
Employees
2
Market Cap
1.53B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202569.33M988.00K1.45%
Jun 30, 202468.34M-4.41M-6.06%
Jun 30, 202372.75M9.36M14.77%
Jun 30, 202263.39M23.24M57.87%
Jun 30, 202140.15M-6.58M-14.08%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition